NantKwest Inc (NK):企業の財務・戦略的SWOT分析

◆英語タイトル:NantKwest Inc (NK) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH327397FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NantKwest Inc (NantKwest), a subsidiary of NantWorks LLC, develops natural killer (NK) cell therapies to treat cancer, infectious and inflammatory diseases by harnessing the immune system. The company is developing drugs against Merkel cell carcinoma 2L, non-small cell lung cancer 3L, multiple myeloma, pancreatic, ovarian, gastric and HER2+ breast cancer. It is also evaluating programs targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with severe and high risk moderate infection. NantKwest utilizes NK cell platform to develop haNK cells that improve the cancer cell killing effect of antibodies; taNK cells that incorporate chimeric antigen receptors (CARs) to target tumor-specific antigens on the surface of cancer cells; and t-haNKs, a combination of haNK and taNK to destroy cancer cells. The company operates offices in California and Massachusetts, the US. NantKwest is headquartered in San Diego, California, the US.

NantKwest Inc Key Recent Developments

Mar 09,2021: ImmunityBio and NantKwest Complete Merger
Feb 18,2021: 2021 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Jan 13,2021: NantKwest, ImmunityBio announce positive interim data on survival rates in metastatic pancreatic cancer trials

This comprehensive SWOT profile of NantKwest Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of NantKwest Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

NantKwest Inc – Key Information
NantKwest Inc – Overview
NantKwest Inc – Key Employees
NantKwest Inc – Key Employee Biographies
NantKwest Inc – Key Operational Heads
NantKwest Inc – Major Products and Services
NantKwest Inc – History
NantKwest Inc – Company Statement
NantKwest Inc – Locations And Subsidiaries
NantKwest Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

NantKwest Inc – Business Description
NantKwest Inc – Corporate Strategy
NantKwest Inc – SWOT Analysis
SWOT Analysis – Overview
NantKwest Inc – Strengths
NantKwest Inc – Weaknesses
NantKwest Inc – Opportunities
NantKwest Inc – Threats
NantKwest Inc – Key Competitors

Section 3 – Company Financial Performance Charts

NantKwest Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

NantKwest Inc, Key Information
NantKwest Inc, Key Ratios
NantKwest Inc, Share Data
NantKwest Inc, Major Products and Services
NantKwest Inc, History
NantKwest Inc, Key Employees
NantKwest Inc, Key Employee Biographies
NantKwest Inc, Key Operational Heads
NantKwest Inc, Other Locations
NantKwest Inc, Subsidiaries
NantKwest Inc, Key Competitors
NantKwest Inc, SWOT Analysis
NantKwest Inc, Ratios based on current share price
NantKwest Inc, Annual Ratios
NantKwest Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[NantKwest Inc (NK):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • InsuLine Medical Ltd (INSL):医療機器:M&Aディール及び事業提携情報
    Summary InsuLine Medical Ltd (InsuLine Medical) is a medical device company that develops, manufactures and markets device which enables patients on intensive insulin therapy. The company offers products such as InsuPad and InsuPatch which are designed to improve the current meal-time insulin therap …
  • Hologic, Inc.:企業の戦略・SWOT・財務情報
    Hologic, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hologic, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SaskEnergy Inc:企業の戦略的SWOT分析
    SaskEnergy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Heron Therapeutics Inc (HRTX):医療機器:M&Aディール及び事業提携情報
    Summary Heron Therapeutics Inc (Heron), formerly A.P. Pharma, Inc., is a biotechnology company that uses its proprietary polymer-based drug delivery platform to develop novel, patient-focused drugs for patients suffering from cancer and pain. Its proprietary Biochronomer technology is a polymer-base …
  • Grand Gulf Energy Ltd (GGE):企業の財務・戦略的SWOT分析
    Summary Grand Gulf Energy Ltd (GGE), formerly Alto Energy International Ltd, is an oil and gas exploration and production company. It acquires, explores and develops conventional oil and gas assets in the US oil and gas basins. In addition, GGE also holds interests in Napoleonville Salt Dome project …
  • Air China Limited:戦略・SWOT・企業財務分析
    Air China Limited - Strategy, SWOT and Corporate Finance Report Summary Air China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Wacker Neuson Se
    Wacker Neuson Se - Strategy, SWOT and Corporate Finance Report Summary Wacker Neuson Se - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • HCA Healthcare, Inc.:戦略・SWOT・企業財務分析
    HCA Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report Summary HCA Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Boart Longyear Ltd:企業の戦略・SWOT・財務情報
    Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report Summary Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Fibra Uno Administracion, S. A. De C. V.:企業の戦略・SWOT・財務分析
    Fibra Uno Administracion, S. A. De C. V. - Strategy, SWOT and Corporate Finance Report Summary Fibra Uno Administracion, S. A. De C. V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • HeartWare International Inc:企業の戦略的SWOT分析
    HeartWare International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • DiscGenics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DiscGenics Inc (DiscGenics) is a biotechnology company that develops advanced spinal therapeutics. The company develops therapies to treat patients with intervertebral disc diseases. It provides products such as Injectable Discogenic Cell Therapy (IDCT), developed for treating patients with …
  • Euler Hermes SA:企業の戦略・SWOT・財務情報
    Euler Hermes SA - Strategy, SWOT and Corporate Finance Report Summary Euler Hermes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PT Soho Global Health Tbk (SOHO):企業の財務・戦略的SWOT分析
    PT Soho Global Health Tbk (SOHO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • MEI Pharma Inc (MEIP):企業の財務・戦略的SWOT分析
    MEI Pharma Inc (MEIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Lincoln Pharmaceuticals Ltd (LINCOLN):企業の財務・戦略的SWOT分析
    Lincoln Pharmaceuticals Ltd (LINCOLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • National Cancer Centre Singapore:製薬・医療:M&Aディール及び事業提携情報
    Summary National Cancer Centre Singapore (NCCS) is a cancer research centre that offers research, education, clinical services, and patient care services. The centre offers services such as medical oncology, oncologic imaging, palliative medicine, pharmacy, psychosocial oncology, public education, r …
  • Hitachi Ltd (6501):企業の財務・戦略的SWOT分析
    Hitachi Ltd (6501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Sojitz Corp (2768):石油・ガス:M&Aディール及び事業提携情報
    Summary Sojitz Corp (Sojitz) is a diversified general trading group. The group through its subsidiaries and affiliates holds interest in machinery; energy and metals; chemicals and functional materials; and consumer lifestyle businesses. It distributes automobiles and aircraft; develops power projec …
  • Clinigen Group Plc (CLIN)-製薬・医療分野:企業M&A・提携分析
    Summary Clinigen Group plc (Clinigen Group) is a pharmaceutical and services company that provides access to medicines, clinical trials, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines including cardioxane, ethyol, foscavir, savene and vibativ. It o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆